| Literature DB >> 36230033 |
Siqi Qiu1, Li Huang1, Ning Xia1, Jianwen Teng1, Baoyao Wei1, Xiaoshan Lin1, Muhammad Rafiullah Khan1,2.
Abstract
Liupao tea is an important dark tea, but few studies on purified Liupao tea polysaccharide (TPS) are reported in the literature. In this study, two TPSs, named TPS2 and TPS5, with molecular weights of 70.5 and 133.9 kDa, respectively, were purified from Liupao tea. TPS2 contained total sugar content (53.73% ± 1.55%) and uronic acid content (35.18% ± 0.96%), while TPS5 was made up of total sugar (51.71% ± 1.1%), uronic acid (40.95% ± 3.12%), polyphenols (0.43% ± 0.03%), and proteins (0.11% ± 0.07%). TPS2 and TPS5 were composed of Man, Rha, GlcA, Glc, Gal, and Ara in the molar ratios of 0.12:0.69:0.20:0.088:1.60:0.37 and 0.090:0.36:0.42:0.07:1.10:0.16, respectively. The effects of TPS2 and TPS5 on digestion and regulation of gut microbiota in hyperlipidemic rats were compared. In simulated digestion, TPS5 was degraded and had good antioxidant effect, whereas TPS2 was not affected. The bile acids binding capacities of TPS2 and TPS5 were 42.79% ± 1.56% and 33.78% ± 0.45%, respectively. During in vitro fermentation, TPS2 could more effectively reduce pH, promote the production of acetic acid and propionic acid, and reduce the ratio of Firmicutes to Bacteroidetes. TPS5 could more effectively promote the production of butyric acid and increase the abundance of genus Bacteroides. Results indicate that polysaccharides without polyphenols and proteins have better antidigestibility and bile acid binding. Meanwhile, polysaccharides with polyphenols and proteins have a better antioxidant property. Both have different effects on the gut microbiota.Entities:
Keywords: Liupao tea polysaccharides; bioactivities; in vitro fermentation; simulated digestion
Year: 2022 PMID: 36230033 PMCID: PMC9564304 DOI: 10.3390/foods11192958
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Figure 1Elution curve of the purification of refined Liupao TPS by DEAE-52 cellulose column (a). Elution curve of the enrichment of TPS2 and TPS5 detected by the phenol–sulfuric acid method (b). Fourier transform infrared spectrogram of TPS2 and TPS5 (c) and ultraviolet-visible spectrogram of TPS2 and TPS5 (d).
Structural characterization of TPS2 and TPS5.
| Item | TPS2 | TPS5 |
|---|---|---|
| Total sugar (W%) | 53.73 ± 1.55 | 51.71 ± 1.16 |
| Uronic acid (W%) | 35.18 ± 0.96 | 40.95 ± 3.12 |
| Protein (W%) | ND | 0.11 ± 0.07 |
| Polyphenol (W%) | ND | 0.43 ± 0.03 |
| Molecular weight (kDa) | 70.591 | 133.867 |
| Monosaccharide composition (mol %) | ||
| Mannose | 0.12 | 0.090 |
| Rhamnose | 0.69 | 0.36 |
| Glucuronic acid | 0.20 | 0.42 |
| Glucose | 0.088 | 0.07 |
| Galactose | 1.60 | 1.10 |
| Arabinose | 0.37 | 0.16 |
ND means not detected.
Figure 2HPGPC chromatograms of TPS2 before and after simulated saliva (a), stomach (b), and small intestinal (c) digestion. HPGPC chromatograms of TPS5 before and after simulated saliva (d), stomach (e), and small intestinal (f) digestion.
Molecular weights and concentrations of reducing sugars of TPS2 and TPS5 during in vitro simulated saliva–gastrointestinal digestion.
| Simulated Digestive Juice | Time (h) | Molecular Weight (kDa) | Reducing Sugar (mM) | ||
|---|---|---|---|---|---|
| TPS2 | TPS5 | TPS2 | TPS5 | ||
| Salivary | 0 | 70.591 ± 0.541 a | 133.867 ± 1.003 a | 0 a | 0 a |
| 1 | 70.591 ± 0.541 a | 133.867 ± 1.003 a | 0 a | 0 a | |
| Gastric | 0 | 70.591 ± 0.541 a | 133.867 ± 1.003 a | 0 a | 0 a |
| 2 | 70.591 ± 0.541 a | 133.867 ± 1.003 a | 0 a | 0 a | |
| 4 | 70.591 ± 0.541 a | 133.867 ± 1.003 a | 0 a | 0 a | |
| 6 | 70.591 ± 0.541 a | 133.867 ± 1.003 a | 0 a | 0 a | |
| Intestinal | 0 | 70.591 ± 0.541 a | 133.867 ± 1.003 a | 0 a | 0 a |
| 2 | 70.591 ± 0.541 a | 124.270 ± 2.120 b | 0 a | 0.679 ± 0.029 b | |
| 4 | 70.591 ± 0.541 a | 123.256 ± 1.534 c | 0 a | 0.743 ± 0.009 c | |
| 6 | 70.591 ± 0.541 a | 122.252 ± 1.180 d | 0 a | 1.028 ± 0.007 d | |
Different letters in the same column indicate a significant difference (p < 0.05).
Figure 3Radical scavenging ability of ABTS (a) and DPPH (b) of TPS2 and TPS5 in simulated digestion. Different letters indicate significant difference (p < 0.05).
In vitro bile acid binding ability of TPS2 and TPS5.
| Treatment | Bile Acid Concentration in Supernatant (μmol/L) | Percentage Bile Acid | Relative to Cholestyramine (50mg), % |
|---|---|---|---|
| TPS2 | 7.32 ± 0.20 b | 42.79 ± 1.56 b | 50.53 ± 1.84 b |
| TPS5 | 8.47 ± 0.06 a | 33.78 ± 0.45 c | 39.89 ± 0.53 c |
| Cholestyramine | 1.95 ± 0.21 c | 84.68 ± 1.62 a | 100.00 ± 1.92 a |
Different letters in the same column indicate significant difference (p < 0.05).
Short-chain fatty acids and ratio of acetic acid to propionic acid at different time points of fermentation.
| SCFAs (mmol/L) | Groups | Fermentation Time (h) | |||
|---|---|---|---|---|---|
| 0 | 12 | 24 | 48 | ||
| Acetic acid | HFD | 7.05 ± 0.68 a, A | 3.82 ± 0.22 b, D | 6.75 ± 0.76 a, D | 3.69 ± 0.20 b, D |
| ND | 7.18 ± 0.23 b, A | 11.76 ± 1.05 a, C | 7.07 ± 0.33 b, D | 4.57 ± 0.34 c, D | |
| TPS2 | 7.10 ± 0.27 d, A | 14.05 ± 0.67 c, C | 23.25 ± 1.44 b, B | 26.63 ± 1.38 a, B | |
| TPS5 | 7.54 ± 0.07 d, A | 26.00 ± 0.50 b, A | 27.52 ± 0.33 a, A | 12.29 ± 0.93 c, C | |
| Inulin | 7.89 ± 0.28 c, A | 18.77 ± 2.35 b, B | 16.99 ± 0.44 b, C | 52.44 ± 1.64 a, A | |
| Propionic acid | HFD | 0.62 ± 0.08 d, A | 1.36 ± 0.07 c, C | 5.19 ± 0.27 b, A | 8.67 ± 0.22 a, B |
| ND | 0.72 ± 0.01 d, A | 5.44 ± 0.23 a, A | 3.24 ± 0.16 b, C | 2.58 ± 0.23 c, C | |
| TPS2 | 0.69 ± 0.20 c, A | 1.49 ± 0.01 c, C | 3.94 ± 0.15 b, B | 6.64 ± 1.76 a, B | |
| TPS5 | 0.56 ± 0.05 c, A | 4.08 ± 0.03 a, B | 3.65 ± 0.02 b, BC | 4.04 ± 0.29 a, C | |
| Inulin | 0.62 ± 0.02 c, A | 0.62 ± 0.07 c, D | 1.49 ± 0.30 b, D | 31.13 ± 0.56 a, A | |
| Butyric acid | HFD | 0.36 ± 0.06 a, A | 0.45 ± 0.07 a, B | 0.37 ± 0.01 a, C | 0.31 ± 0.08 a, E |
| ND | 0.29 ± 0.04 c, A | 2.45 ± 0.11 b, A | 2.62 ± 0.06 b, A | 2.84 ± 0.06 a, A | |
| TPS2 | 0.38 ± 0.03 b, A | 0.61 ± 0.15 ab, B | 0.41 ± 0.08 b, C | 0.71 ± 0.07 a, D | |
| TPS5 | 0.38 ± 0.13 c, A | 0.72 ± 0.13 b, B | 0.90 ± 0.06 b, B | 1.64 ± 0.09 a, B | |
| Inulin | 0.29 ± 0.04 c, A | 0.61 ± 0.01 b, B | 0.26 ± 0.04 c, C | 1.16 ± 0.09 a, C | |
| Total | HFD | 8.03 ± 0.62 c, A | 5.63 ± 0.23 b, D | 12.31 ± 0.51 a, D | 12.67 ± 0.21 a, D |
| ND | 8.20 ± 0.24 c, A | 19.65 ± 1.38 a, B | 12.93 ± 0.30 b, D | 10.00 ± 0.34 c, D | |
| TPS2 | 8.17 ± 0.39 d, A | 16.15 ± 0.73 c, C | 27.60 ± 1.61 b, B | 33.97 ± 1.83 a, B | |
| TPS5 | 8.48 ± 0.07 d, A | 30.80 ± 0.60 b, A | 32.07 ± 0.30 a, A | 17.97 ± 1.17 c, C | |
| Inulin | 8.80 ± 0.27 c, A | 20.00 ± 2.28 b, B | 18.74 ± 0.63 b, C | 84.72 ± 1.04 a, A | |
| Acetic acid/Propionic acid | HFD | 11.41 ± 1.83 a, A | 2.82 ± 0.26 b, B | 1.31 ± 0.21 b, C | 0.43 ± 0.03 b, D |
| ND | 9.92 ± 0.36 a, A | 2.16 ± 0.11 b, B | 2.19 ± 0.19 b, C | 1.78 ± 0.27 b, BC | |
| TPS2 | 10.97 ± 3.29 a, A | 9.43 ± 0.40 ab, B | 5.90 ± 0.19 bc, B | 4.26 ± 1.44 c, A | |
| TPS5 | 13.44 ± 1.19 a, A | 6.38 ± 0.12 b, B | 7.54 ± 0.06 b, B | 3.05 ± 0.19 c, AB | |
| Inulin | 12.77 ± 0.13 b, A | 30.78 ± 7.03 a, A | 11.75 ± 2.46 b, A | 1.69 ± 0.08 c, BC | |
Different minuscules show significant differences at different time (p < 0.05) in the same group, while capitals represent significant differences among different groups (p < 0.05) at the same time point.
Figure 4Microbiota composition during in vitro fermentation. Relative abundance of bacterial community at the phylum level (a), family level (b), and genus level (c). Cladogram of LEfSe of 48 h fermentation samples; TPS2 and TPS5 (d); ND, HFD, TPS2, TPS5, and inulin (e).